MX2023002667A - Compuestos y metodos para el tratamiento de infecciones virales. - Google Patents

Compuestos y metodos para el tratamiento de infecciones virales.

Info

Publication number
MX2023002667A
MX2023002667A MX2023002667A MX2023002667A MX2023002667A MX 2023002667 A MX2023002667 A MX 2023002667A MX 2023002667 A MX2023002667 A MX 2023002667A MX 2023002667 A MX2023002667 A MX 2023002667A MX 2023002667 A MX2023002667 A MX 2023002667A
Authority
MX
Mexico
Prior art keywords
viral infection
compounds
methods
coronaviruses
treating viral
Prior art date
Application number
MX2023002667A
Other languages
English (en)
Inventor
Ameer E Hassan
Yousef Hasan Ahmad Khalili
Original Assignee
Ameer E Hassan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ameer E Hassan filed Critical Ameer E Hassan
Publication of MX2023002667A publication Critical patent/MX2023002667A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Abstract

La presente divulgación se refiere a compuestos y métodos para tratar síntomas o secuelas resultantes de una infección viral, incluida la infección por influenza, rinovirus o betacoronavirus, como coronavirus humanos como los coronavirus SARS, coronavirus MERS y COVID-19, incluido el Síndrome de Dificultad Respiratoria Aguda (ARDS) asociado con la infección viral.
MX2023002667A 2020-09-04 2021-09-03 Compuestos y metodos para el tratamiento de infecciones virales. MX2023002667A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063074602P 2020-09-04 2020-09-04
US202163142669P 2021-01-28 2021-01-28
PCT/US2021/048991 WO2022051575A2 (en) 2020-09-04 2021-09-03 Compounds and methods for treating viral infection

Publications (1)

Publication Number Publication Date
MX2023002667A true MX2023002667A (es) 2023-05-12

Family

ID=80491477

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023002667A MX2023002667A (es) 2020-09-04 2021-09-03 Compuestos y metodos para el tratamiento de infecciones virales.

Country Status (7)

Country Link
US (1) US20230346816A1 (es)
EP (1) EP4208137A2 (es)
JP (1) JP2023541007A (es)
CA (1) CA3194024A1 (es)
MX (1) MX2023002667A (es)
TW (1) TW202228730A (es)
WO (1) WO2022051575A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023205718A2 (en) * 2022-04-21 2023-10-26 Hassan Ameer E Methods of treating inflammation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1533776A (zh) * 2003-03-27 2004-10-06 中国人民解放军第三军医大学 N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用
JP5807895B2 (ja) * 2011-02-17 2015-11-10 学校法人慶應義塾 Ｈｃｖｒｎａ複製抑制剤
CA2832859C (en) * 2011-04-15 2020-06-16 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acetylglucosamine nanofibers

Also Published As

Publication number Publication date
CA3194024A1 (en) 2022-03-10
TW202228730A (zh) 2022-08-01
WO2022051575A3 (en) 2022-04-07
US20230346816A1 (en) 2023-11-02
WO2022051575A2 (en) 2022-03-10
JP2023541007A (ja) 2023-09-27
EP4208137A2 (en) 2023-07-12

Similar Documents

Publication Publication Date Title
CY1120079T1 (el) Υδατικη συνθεση που περιεχει βρωμεξινη
MX2021014742A (es) Peptidomimeticos para el tratamiento de infecciones por coronavirus y picornavirus.
MX2022010874A (es) Lactoferrina de uso oral con accion antiviral.
EA201792429A1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
PH12017501534A1 (en) Antiviral compounds
PH12016500332B1 (en) Antiviral compounds
EA201690526A1 (ru) Замещенные нуклеозиды, нуклеотиды и их аналоги
EA201890722A1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
WO2022221440A8 (en) Influenza-coronavirus combination vaccines
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
EA201790758A1 (ru) Производные моно- или дизамещенных индолов в качестве ингибиторов репликации вирусов денге
EA201791614A1 (ru) Производные индола в качестве ингибиторов репликации вирусов денге
EA201690335A1 (ru) Новые средства для уменьшения негативных последствий курения
EA201790700A1 (ru) Моно- или дизамещенные индолы в качестве ингибиторов репликации вирусов денге
CL2011002494A1 (es) Compuestos derivados de 7-aza-di-espiro-[3.0.4.1]-decan-8-carboxamida; composición farmacéutica que los comprenden; y uso para el tratamiento de un trastorno asociado con el virus de la hepatitis c (hcv) y el virus de inmunodeficiencia humana (vih).
MX340190B (es) Compuestos para tratar infecciones por virus sincitial respiratorio.
UY32720A (es) Combinaciones farmaceuticas utiles para el tratamiento del virus de la hepatitis c (vhc), usos y metodos relacionados
PH12016500465A1 (en) Deoxynojirimycin derivatives and methods of their using
UY32721A (es) Composiciones farmacéuticas útiles para tratar el virus de la hepatitis c (vhc), usos y métodos relacionados
BR112018003086A2 (pt) processo para captura de dióxido de carbono e dessalinação
PE20081215A1 (es) Identificacion y caracterizacion de variantes de replicon de vhc con menor susceptibilidad a vhc-796, y metodos relacionados
MX2023002667A (es) Compuestos y metodos para el tratamiento de infecciones virales.
ATE380188T1 (de) Substituierte chinolone
CL2023000699A1 (es) Tratamientos de angioedema
IN2014DN03382A (es)